{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:10:43Z","timestamp":1761408643523,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"2018 Research Grant for young medical doctors and healthcare professionals from SRL, Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.pan.2019.02.010","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T11:00:13Z","timestamp":1550919613000},"page":"419-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of BRCAness with multiplex ligation-dependent probe amplification using formalin-fixed and paraffin-embedded pancreatic ductal adenocarcinoma tissue obtained via endoscopic ultrasound-guided fine-needle aspiration biopsy"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3671-1299","authenticated-orcid":false,"given":"Kosuke","family":"Okuwaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Masutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Kida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Tadehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kurosu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasaburo","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2019.02.010_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000123838","article-title":"Pancreatic carcinogenesis","volume":"8","author":"Koorstra","year":"2008","journal-title":"Pancreatology"},{"key":"10.1016\/j.pan.2019.02.010_bib2","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA A Cancer J Clin"},{"year":"2016","series-title":"Monitoring of cancer incidence in Japan - survival 2006-2008 report","key":"10.1016\/j.pan.2019.02.010_bib3"},{"key":"10.1016\/j.pan.2019.02.010_bib4","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pan.2019.02.010_bib5","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pan.2019.02.010_bib6","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrc1457","article-title":"Hallmarks of 'BRCAness' in sporadic cancers","volume":"4","author":"Turner","year":"2004","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.pan.2019.02.010_bib7","first-page":"80","article-title":"BRCAness predicts resistance to taxane-containing regimens in triple negative breast cancer during neoadjuvant chemotherapy","volume":"15","author":"Akashi-Tanaka","year":"2015","journal-title":"Clin Breast Canc"},{"key":"10.1016\/j.pan.2019.02.010_bib8","doi-asserted-by":"crossref","first-page":"e0165721","DOI":"10.1371\/journal.pone.0165721","article-title":"BRCAness and prognosis in triple-negative breast cancer patients treated with neoadjuvant chemotherapy","volume":"11","author":"Tanino","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pan.2019.02.010_bib9","doi-asserted-by":"crossref","first-page":"e0167016","DOI":"10.1371\/journal.pone.0167016","article-title":"BRCAness as a biomarker for predicting prognosis and response to anthracycline-based adjuvant chemotherapy for patients with triple-negative breast cancer","volume":"11","author":"Mori","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pan.2019.02.010_bib10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/jmg.40.12.907","article-title":"Rapid, high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA)","volume":"40","author":"Slater","year":"2003","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.pan.2019.02.010_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PDM.0b013e3182595516","article-title":"Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics","volume":"21","author":"H\u00f6mig-H\u00f6lzel","year":"2012","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.pan.2019.02.010_bib12","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1093\/nar\/gnf056","article-title":"Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification","volume":"30","author":"Schouten","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pan.2019.02.010_bib13","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1093\/annonc\/mdr621","article-title":"Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapy","volume":"23","author":"Oonk","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pan.2019.02.010_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10549-008-0117-z","article-title":"Prediction of BRCA1-association in hereditary non-BRCA1\/2 breast carcinomas with array-CGH","volume":"116","author":"Joosse","year":"2009","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.pan.2019.02.010_bib15","doi-asserted-by":"crossref","first-page":"7508","DOI":"10.1158\/1078-0432.CCR-05-1048","article-title":"In\u00a0vivo therapeutic responses contingent on Fanconi anemia\/BRCA2 status of the tumor","volume":"11","author":"van der Heijden","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pan.2019.02.010_bib16","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/bjc.2014.418","article-title":"Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers","volume":"111","author":"Golan","year":"2014","journal-title":"Br J Canc"},{"key":"10.1016\/j.pan.2019.02.010_bib17","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1634\/theoncologist.2011-0185","article-title":"An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions","volume":"16","author":"Lowery","year":"2011","journal-title":"Oncol"},{"key":"10.1016\/j.pan.2019.02.010_bib18","doi-asserted-by":"crossref","first-page":"19817","DOI":"10.18632\/oncotarget.24865","article-title":"Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer","volume":"9","author":"Kondo","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.pan.2019.02.010_bib19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pan.2019.02.010_bib20","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/cncr.31218","article-title":"Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: germline BRCAmutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma","volume":"124","author":"O'Reilly","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.pan.2019.02.010_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1470-2045(16)30559-9","article-title":"Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial","volume":"18","author":"Swisher","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pan.2019.02.010_bib22","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1056\/NEJMoa1611310","article-title":"Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer","volume":"375","author":"Mirza","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pan.2019.02.010_bib23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0016-5107(92)70385-X","article-title":"Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease","volume":"38","author":"Vilmann","year":"1992","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.pan.2019.02.010_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-0032-1326268","article-title":"Randomized trial comparing fanning with standard technique for endoscopic ultrasound-guidedfine-needle aspiration of solid pancreatic mass lesions","volume":"45","author":"Bang","year":"2013","journal-title":"Endoscopy"},{"key":"10.1016\/j.pan.2019.02.010_bib25","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1007\/s10620-013-3019-9","article-title":"Slow pull versus suction in endoscopic ultrasound-guided fine-needle aspiration of pancreatic solid masses","volume":"59","author":"Nakai","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.pan.2019.02.010_bib26","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0016-5107(94)70112-1","article-title":"Endoscopic ultrasound-guided fine-needle aspiration","volume":"40","author":"Chang","year":"1994","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.pan.2019.02.010_bib27","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1572-0241.2003.07472.x","article-title":"Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration","volume":"98","author":"Klapman","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pan.2019.02.010_bib28","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.gie.2010.01.029","article-title":"An evaluation of risk factors for inadequate cytology in EUS-guided FNA of pancreatic tumors and lymph nodes","volume":"71","author":"Cleveland","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.pan.2019.02.010_bib29","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/ajg.2011.119","article-title":"Influence of on-site cytopathology evaluation on the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of solid pancreatic masses","volume":"106","author":"Iglesias-Garcia","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pan.2019.02.010_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.gie.2014.08.040","article-title":"Macroscopic on-site quality evaluation of biopsy specimens to improve the diagnostic accuracy during EUS-guided FNA using a 19-gauge needle for solid lesions: a single-center prospective pilot study (MOSE study)","volume":"81","author":"Iwashita","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.pan.2019.02.010_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","article-title":"Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes","volume":"53","author":"Almoguera","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.pan.2019.02.010_bib32","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1572-0241.2002.05980.x","article-title":"Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor","volume":"97","author":"Tada","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pan.2019.02.010_bib33","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1055\/s-0029-1214717","article-title":"Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudo tumoral chronic pancreatitis","volume":"41","author":"Bournet","year":"2009","journal-title":"Endoscopy"},{"key":"10.1016\/j.pan.2019.02.010_bib34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/MPA.0b013e3182200201","article-title":"Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses","volume":"40","author":"Reicher","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2019.02.010_bib35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s00535-012-0664-2","article-title":"Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer","volume":"48","author":"Ogura","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.pan.2019.02.010_bib36","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.3748\/wjg.v13.i27.3714","article-title":"Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer","volume":"13","author":"Salek","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pan.2019.02.010_bib37","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1002\/ijc.22997","article-title":"Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas","volume":"121","author":"Wang","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pan.2019.02.010_bib38","doi-asserted-by":"crossref","first-page":"64440","DOI":"10.18632\/oncotarget.16135","article-title":"Additional K-ras mutation analysis and Plectin-1 staining improve the diagnostic accuracy of pancreatic solid mass in EUS-guided fine needle aspiration","volume":"8","author":"Park","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pan.2019.02.010_bib39","first-page":"83","article-title":"Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer","volume":"28","author":"Ashida","year":"2009","journal-title":"J\u00a0Exp Clin Canc Res"},{"key":"10.1016\/j.pan.2019.02.010_bib40","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/annonc\/mdq624","article-title":"An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients","volume":"22","author":"Vollebergh","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pan.2019.02.010_bib41","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/bcr3049","article-title":"Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness","volume":"13","author":"Lips","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.pan.2019.02.010_bib42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/jmg.40.12.907","article-title":"Rapid, high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA)","volume":"40","author":"Slater","year":"2003","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.pan.2019.02.010_bib43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PDM.0b013e3182595516","article-title":"Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics","volume":"21","author":"H\u00f6mig-H\u00f6lzel","year":"2012","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.pan.2019.02.010_bib44","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0002-9440(10)64472-0","article-title":"Effect of fixatives and tissue processing on the content and integrity of nucleic acids","volume":"161","author":"Srinivasan","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pan.2019.02.010_bib45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/pin.12164","article-title":"Optimal fixation for total pre analytic phase evaluation in pathology laboratories: a comprehensive study including immunohistochemistry, DNA, and mRNA assays","volume":"64","author":"Sato","year":"2014","journal-title":"Pathol Int"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390319300341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390319300341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:07:36Z","timestamp":1761408456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390319300341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1424390319300341"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2019.02.010","relation":{},"ISSN":["1424-3903"],"issn-type":[{"type":"print","value":"1424-3903"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of BRCAness with multiplex ligation-dependent probe amplification using formalin-fixed and paraffin-embedded pancreatic ductal adenocarcinoma tissue obtained via endoscopic ultrasound-guided fine-needle aspiration biopsy","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2019.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 IAP and EPC. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}